Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region.
Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults.
The magnitude of interferon-gamma responses to human cytomegalovirus is predictive for HIV-1 disease progression.
Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells.
Once- or twice-daily dosing of nevirapine in HIV-infected adults: a population pharmacokinetics approach.
Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.
HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro.
[Position of darunavir in antiretroviral therapy].
Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption.
Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.